Form4insider filings, from the source

Insider holders · CIK 0001419041

Forte Biosciences, Inc. · FBRX

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
Harry E GruberPresident, Research & Devel2,500417,753420,253Dec 14, 2017 · 8:51 pm ESTForm 4
Douglas JollyEVP, Research & Pharm Devel392,04321,739413,782Dec 14, 2017 · 8:46 pm ESTForm 4
Thomas E DarcyExecutive Vice President—369,565369,565Apr 12, 2017 · 6:25 pm EDTForm 3
Dennis N BermanEVP, Corp Development—246,376246,376Apr 12, 2017 · 6:24 pm EDTForm 3
Faheem HasnainDirector—202,857202,857Apr 21, 2017 · 5:28 pm EDTForm 4
Paul SchimmelDirector23,46413,62337,087Apr 21, 2017 · 5:34 pm EDTForm 4
Franklin M BergerDirector25,335—25,335Apr 21, 2017 · 5:37 pm EDTForm 4
Mark G FolettaEVP & Chief Financial Officer7,500—7,500Dec 14, 2017 · 9:07 pm ESTForm 4
Martin J DuvallChief Executive Officer6,071—6,071Dec 14, 2017 · 9:02 pm ESTForm 4
Asha DasSVP & Chief Medical Officer5,000—5,000Dec 14, 2017 · 9:10 pm ESTForm 4
Steven KornfeldDirector0—0Aug 27, 2026 · 4:36 pm EDTForm 4
Paul A. WagnerSEE REMARKS0—0Aug 27, 2026 · 4:28 pm EDTForm 4
Antony A RileyCHIEF FINANCIAL OFFICER0—0Aug 27, 2026 · 4:28 pm EDTForm 4
David W GryskaDirector0—0Aug 27, 2026 · 4:33 pm EDTForm 4

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.